Indegene's BioPharm Communications used an automated engagement platform to reach HCPs in vacant and low-access territories.
The company could not reach healthcare professionals in low-access territories during launch. BioPharm Communications, an Indegene subsidiary, deployed the automated C.O.V.E.R. platform with segmented audience journeys, CRM-integrated engagement data and marketing-qualified leads. The page reports 51,583 HCP engagements across 38,202 targeted HCPs, a 27.5% engagement rate, a 38.4% lift in prescriptions and 8.7:1 ROI.
Indegene is a healthcare commercialization and technology services firm, used by pharma for AI-assisted content and campaign creation, omnichannel HCP engagement and commercial analytics
This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.
Published by Indegene on its own site — read the original case study on indegene.com ↗
Related use cases
- 01A pharma launching a new brand used Indegene's agentic AI agency model with compliance built in.
- 02Indegene replaced a 12-16 week agency creative process with an agentic AI co-creation model run in three days.
- 03Indegene built an ML patient-journey model to explain why patients switch androgen deprivation therapies.
- 04Indegene built an element-level framework to score how faithfully global promotional and medical content is localised.
- 05Indegene segmented about 5,000 HCPs and sent localised formulary messaging to close a perceived access gap.
- 06Indegene unified commercial data and added a GenAI interface to model vaccine demand across retail and non-retail channels.